Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
John C. Lindon(Imperial College London), Craig E. Thomas(Eli Lilly (United States)), U Niederhäuser(Roche (Switzerland)), Jeremy K. Nicholson(Imperial College London), Lois D. Lehman‐McKeeman(Bristol-Myers Squibb (United States)), Michael D. Reily(Pfizer (United States)), Ulla G. Sidelmann(Novo Nordisk (Denmark)), Elaine Holmes(Imperial College London), Goetz Schlotterbeck(Roche (Switzerland)), Olaf Beckonert(Imperial College London), Roy H. Bible, Hector C. Keun(Hammersmith Hospital), Gregory J. Stevens(Pfizer (United States)), Ali Loukaci(Eli Lilly (United States)), Timothy M. D. Ebbels(Imperial College London), Mary E. Bollard(Imperial College London), Alan P. Breau, Adrienne A. Tymiak(Bristol-Myers Squibb (United States)), Steen Møller Laursen(Novo Nordisk (Denmark)), Donald G. Robertson(Pfizer (United States)), Peter Luke(Pfizer (United Kingdom)), Jean-Marie Colet(Eli Lilly (United States)), Glenn H. Cantor, Bruce D. Car(Bristol-Myers Squibb (United States)), Hans Senn(Roche (Switzerland)), Henrik Antti(Umeå University)
Cited by 386
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data
|Xenobiotica|1999|3.9k
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
|Nature Protocols|2007|2.1k
Metabonomics: a platform for studying drug toxicity and gene function
|Nature Reviews Drug Discovery|2002|1.9k
Metabonomics
|Nature|2008|1.9k